News & Insights
Find all the latest research, news, and CEOi workgroup resources on digital cognitive assessments, blood-based biomarkers, and more breakthroughs in diagnostic tools and assessments for Alzheimer’s disease.
Featured
Stories
Roche’s Elecsys® pTau181 Becomes the Only FDA-Cleared Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
Go To Resource
News and Insight Library for Alzheimer’s Diagnostic Tools and Assessments
Interchangeability of blood‐based biomarkers and PET to identify Alzheimer’s disease pathology
Go To Resource
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
Go To Resource
Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United States
Go To Resource
The Global CEO Initiative on Alzheimer’s Disease Publishes Consensus Recommendations for Clinic-Based Digital Cognitive Assessments
Go To Resource
Roche’s Elecsys® pTau181 Becomes the Only FDA-Cleared Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
Go To Resource